CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓNEN ENFERMEDADESNEURODEGENERATIVAS
IVIV INTERNATIONAL CONGRESS ON RESEARCH AND INNOVATION INNEURODEGENERATIVE DISEASES
IVIV
2016SeptiembreSeptiembre
21 - 23September September ALICANTEALICANTE
Avenida de Europa, 4,E-03008 Alicante, España.
VENUE:
intEllEctuAl propErty officEEuropEAn union
Scientific
Scientific
10:00 - 15:00 Welcome and registration Posters set-up
With the Presidency of Her Majesty the Queen Sofia
12:00 - 12:15 OFFICIAL OPENING
12:15 - 13:15 KEYNOTE LECTURE Introduced by: Jesús Ávila
Bengt Winblad, Karolinska Institute, Stockholm, Sweden. “Alzheimer´s Disease - Present and future Treatment Strategies”.
13:15 - 15:00 Lunch and poster SESSION
15:00 - 16:30 PLENARY SESSION I 15:00 - 15:45 Introduced by: José Ángel Obeso Anthony Schapira, UCL, London, UK.
“The Glucocerebrosidase pathway: a paradigm for pathogenesis and treatment in Parkinson disease”.
15:45 - 16:30 Introduced by: Miguel Medina Eckhard Mandelkow, DZNE, Bonn-Germany.
“Role of Tau protein in Alzheimer Disease and neurodegenerative tauopathies: Structure and cellular functions”.
Wednesday, 21st
Scientific
16:30 - 17:00Coffee break
17:00 - 18:15 Scientific Session I
Chairperson: Guadalupe Mengod
17:00 - 17:20 José Ramón Naranjo, CIBERNED, National Center of Biotechnology, CSIC, Madrid. “DREAM regulates ATF6 processing and HD progression”.
17:20 - 17:40 Eva Carro, CIBERNED, 12 de Octubre University Hospital, Madrid.“Metabolic Disorders and inflammation as riskfactors for alzheimer’s disease”.
17:40 - 18:00 Carlos Vicario, CIBERNED, Cajal Institute, CSIC, Madrid. “Using pluripotent stem cell technology to study neurodegeneration in Parkinson´s and Alzheimer´s diseases”.
18:00 - 18:15 María del Mar Puigdellívol. 2015 Young
Investigator Award. University of East Anglia, Norwich research Park. United kingdom. CIBERNED, University of Barcelona. “A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington´s disease”.
Wednesday, 21st
Scientific
18:45 Transfer Bus from venue to Hotel Meliá Alicante.
19:30 Transfer Bus from Hotel Meliá Alicante to Reception at the Santa Bárbara Castle.
20:00 Reception at the Santa Bárbara Castle.
Return to the hotel by transfer Bus.
Wednesday, 21stWednesday, 21st
Scientific
Thursday, 22nd
08:00 Transfer Bus from Hotel Meliá Alicante to venue.
08:30 - 09:30 Meetings of Cooperative Projects. (Closed Session)
09:00 Transfer Bus from Hotel Meliá Alicante to venue.
09:30 - 10:50 Scientific Session II
Chairperson: Adolfo López de Munain
09:30 - 09:50 Alberto Lleó, CIBERNED, Santa Creu i Sant Pau Hospital, Barcelona. “Synaptic abnormalities in Alzheimer’s disease and other dementias”.
09:50 - 10:10 Jordi Pérez-Tur, CIBERNED, Institute of Biomedicine of Valencia-CSIC.
“Genetic landscape in Parkinson´s disease”.
10:10 - 10:30 Eduardo Tolosa, CIBERNED, Hospital Clinic of Barcelona.
“Biomarkers of prodromal Parkinson disease”.
10:30 - 10:50 José López-Barneo, CIBERNED, Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio, University Hospital, University of Sevilla.“Strategies for a GDNF-based therapy in Parkinson disease”.
Thursday, 22nd
Scientific
11:00 - 11:30 Awarding of Fundación Reina Sofía-MAPFRE Grant. Olatz Arteaga
11:30 – 11:45Coffee break
11:45 - 13:10 PLENARY SESSION II 11:45 - 12:30 Introduced by: Miguel Medina Luc Buée, University of Lille, France.
“Tau experimental models and therapeutic strategies”.
12:30 - 12:50 Juan Carlos López, Head of Academic Relations and Collaborations, Roche, New York, USA. “Challenges and opportunities in transfer of knowledge from academy to industry“.
12:50 - 13:10 David Pardoe, MRC Technologies Dementia Consortium. “Collaborative Drug Discovery Opportunities for Neurodegenerative Diseases - The Dementia Consortium”.
13:15- 15:00 Lunch and poster session
Thursday, 22nd
Scientific
13:15 - 15:00 CIBERNED Steering Committee (Closed Session)
15:00 - 16:15 Scientific Session III
Chairperson: Juan Carlos López
15:00 - 15:15 Antonio Gómez, Janssen.
“New Models to Fulfill the Potential of BasicResearch”.
15:15 - 15:30 Carlos Buesa, Oryzon Genomics.
“LSD1 an epigenetic therapeutic target to modulate different Neurodegenerative Disorsers”.
15:30 - 15:45 Javier Burgos, NeuronBio.
“AlzTEST®, a novel tool in blood for the diagnosis of Alzheimer’s disease”.
15:45 - 16:00 Ainhoa Alzualde, Biobide.
“ZebrafishasatoolforDrugDiscoveryandTargetValidation in neurodegenerative diseases”.
16:00 - 16:15 Raúl Insa, SOM Biotech.
“Repurposing drugs in Neurodegenerative Disorders”.
Thursday, 22nd
Scientific
16:15 - 17:00 Round table. “Transfer of knowledge and industry-academia interaction in neurodegenerative diseases”.
17:00 - 17:30Coffee break
17:30 - 18:30 Claustro CIBERNED.
17:30 - 17:50 ScientificDirectorReport.Jesús Ávila.
17:50 - 18:10 Manager Report. M. Ángeles Pérez.
18:10 - 18:30 DeputyScientificDirectorReport.Miguel Medina.
18:45 Transfer Bus from venue to Hotel Meliá Alicante.
20:00 - 21:00 Alicante walking tour.
21:00 Dinner in a typical restaurant.
Thursday, 22ndThursday, 22nd
Scientific
08:00 Transfer Bus from Hotel Meliá Alicante to venue.
08:30 - 09:30 Meetings of Cooperative Projects. (Closed Session)
09:00 Transfer Bus from Hotel Meliá Alicante to venue.
09:30 - 11:00 Scientific Session IV: Late-breaking news/poster highlights
Chairperson: Javier Sáez-Valero
11:00 - 11:30Coffee break and posters
Friday, 23rd
Scientific
Friday, 23rd
11:30 - 13:10 Scientific Session V Chairperson: María Asunción Pastor 11:30 - 11:50 José Luis Labandeira, CIBERNED, Center for
Research in Molecular Medicine and Chronic Diseases (CIMUS),University of Santiago de Compostela.
”Brain Renin-angiotensin system and dopaminergic degeneration”.
11:50 - 12:10 Manuel Rodríguez, CIBERNED, University of La
Laguna, Santa Cruz de Tenerife. ”Astrocytes in Parkinson´s disease: supporting the
dopaminergic integrity”. 12:10 - 12:30 Ana M. Pérez-Castillo, CIBERNED, Institute
Biomedical Research, CSIC-UAM, Madrid. “Phosphodiesterase-7 as a therapeutic target in
Parkinson’s disease”. 12:30 - 12:50 Valentín Ceña, CIBERNED, University of Castilla-
La Mancha, Albacete. “Nanomedicine:The future for therapeutics of
neurodegenerative diseases?”. 12:50 - 13:10 Javier Sáez-Valero, CIBERNED, Miguel Hernández
University (Elche), CSIC, Neurosciences Institute, Alicante.“Amyloid-related proteins as potential CSF biomarkers for Alzheimer’s disease”.
13:15 Concluding remarks
13:30 End of meeting
Friday, 23rd
General
General
FUNDACIÓN CIEN & CIBERNED SECRETARIAT:
Almudena FloresSoledad ValeroC/ Valderrebollo, 5 - 28031 [email protected] / [email protected]: (+34) 91 385 22 00 · Fax: (+34) 91 385 21 18Mobile Phone (+34) 638 96 26 99 (+34) 638 11 72 55www.fundacioncien.es / www.ciberned.es
CONGRESS SECRETARIAT:
OASIS EVENTS & TRAVEL SOLUTIONSC/ Sor Ángela de la Cruz , 8 - 1º A - 28020 Madrid.Phone: (+34) 91 555 11 19 · Fax: (+34) 91 555 35 81www.viajesoasis.com / [email protected]
VENUE:
EUIPOAvenida de Europa, 4, E-03008 Alicante, España.centro de información: +34 965 139 100
IN GRATITUDE TO:
AyuntAmiento de AlicAnte
intEllEctuAl propErty officEEuropEAn union
intEllEctuAl propErty officEEuropEAn union
Scientific
Notas
Scientific
Notas
Neurogenesis in vitro.Neurosphere cultures were derived from the subventricular zone of
adult rats, grown for 7 days, and then adhered for 3 days to allow differentiation. Cultures were labeled with the neuronal markers TuJ-1
(green) and MAP-2 (red). DAPI was used for nuclear stainingAutores: Jose A. Morales-García & Ana Pérez-Castillo.
COVER PICTURE:
é
Scientific
CONGRESO INTERNACIONALDE INVESTIGACIÓN E INNOVACIÓNEN ENFERMEDADESNEURODEGENERATIVAS
IVIV
INTERNATIONALON RESEARCH AND INNOVATION INNEURODEGENERATIVE DISEASES
IVIV CONGRESS
2016SeptiembreSeptiembre
21 - 23September September
ALICANTEALICANTEwww.fundacioncien.es
www.ciberned.es
#ciiien
www.fundacionreinasofia.es
